ArticleWorld journal of urology2025
Persistence of nocturia after BPH surgery: a multicenter study.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNocturia may be one of the most persistent and bothersome lower urinary tract symptoms (LUTS) in men treated for benign prostatic obstruction (BPO). This study aimed to evaluate the evolution of nocturia after endoscopic enucleation of the prostate (EEP) and identify predictors of no postoperative improvement.
methodsWe conducted a multicenter retrospective study of 120 men who underwent EEP for LUTS/BPO and nocturia evaluation using voiding diaries. Patients with isolated nocturia were not considered for surgery. Outcomes were categorized into complete remission, partial improvement, stability, or worsening.
resultsAt a median follow-up of 15 months, 45% of patients achieved complete remission of nocturia, 19% experienced partial improvement, 30% remained stable, and 6% worsened. The median time for improvement was 6 months. Cox regression analysis identified predominant overactive bladder symptoms as the only significant predictor of no response (HR 1.68; 95% CI, 1.01-2.82; p = 0.04). No significant association was found with age, body mass index, prostate volume, or cardiometabolic comorbidities.
conclusionsThis multicenter study highlights that while nocturia often persists after EEP, nearly two-thirds of patients experience meaningful improvement, emphasizing both the potential benefit of surgery and the multifactorial nature of the symptom.
Indexed as
Identifiers
40540131What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.